Varicocele Treatment Market information, by grade (Grade I, Grade II, Grade III, and others), diagnosis (physical exam, imaging test, and others), by treatment (Varicocele repair, Varicocele Embolization, and others), by end-user- Forecast till 2032

Varicocele Treatment Market Overview

The Varicocele Treatment Market size is projected to reach USD 0.6 Billion by 2032 at 6.5 % CAGR during the forecast period 2023-2032

The global market is enhancing due to the growing competition in the medical sector for the treatment of varicocele. Varicocele is vein enlargement within the scrotum that affects the testes. The rise in the number of varicocele patients has led to the demand for effective treatments. Besides, the increased rate of awareness among the public is also driving the market. Are leading the growth of the market. 

Advancements in treatment and diagnostics are the key growth factors helping the market to propel. The demand from emerging countries like Asia is enhancing the market’s performance. The research and development by the hospitals, academic institutes, and research centers for effective treatment is another important factor accelerating the market’s growth.

The increased growth of healthcare expenditure, the presence of various treatment options, and the government funding and initiatives are spreading more awareness about the disease, expanding the Varicocele Treatment Market.

Study objectives of varicocele treatment market:

• To provide detailed analysis of the market structure with historical and forecast revenue for the next six years of the various segments and sub-segments.


• To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of global varicocele treatment market


• To provide analysis of the market with respect to various countries in the four main geographies– the Americas, Europe, Asia Pacific, and Middle East & Africa.


• To provide detailed analysis of the market segmented by grade, diagnosis, treatment, end user, and its sub-segments.


• To provide a detailed analysis of the market mainly based on Value Chain Analysis, Porter’s Five Forces, Price Analysis, and Supply Chain Analysis etc.


• To provide a detailed country level analysis of the market with respect to the current market size and future prospects


• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global varicocele treatment market


• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the varicocele treatment market

FIGURE 1    GLOBAL VARICOCELE TREATMENT MARKET SHARE BY GRADE, 2016 (%)

Sources: Directorate of Industries, Annual report, White paper, Company Presentation

Intended Audience:

• Varicocele medicines manufacturers


• Varicocele medicines and treatment providers


• Medical research laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors

Research Methodology:

 Sources: Directorate of Industries, Annual report, White paper, Company Presentation

Segments:  

Global Varicocele treatment market has been segmented on the basis of grade which comprises of grade I, grade II, grade III, and others.

On the basis of diagnosis it is segmented into physical exam, imaging test, and others. Imaging test further sub-segmented into thermography, scrotal ultrasound, and others

On the basis of treatments, the market has been segmented into varicocele repair, varicocele embolization, medication, and others. Varicocele repair is sub-segmented into open surgery, laparoscopic surgery, percutaneous embolization, and others. Medication is sub-segmented into painkillers, and others. Painkillers includes acetaminophen, ibuprofen, and others.

On the basis of end user, it is segmented into hospital and clinics, medical research centers, academic institutes, and others.Recent Development

In April 2022

La Jolla Vein & Vascular is the regional leader in vein treatment. It has recently announced the expansion of its vascular services, including endovascular procedures. This treatment procedure is dependent on advanced medical imaging in real-time. LJVV’s newest hire, Dr. Elliot DeYoung, is spearheaded the vascular services. He is specialized in interventional radiology and offers expertise in vascular disease, embolization, angioplasty, stenting, ablation, and more. 

In October 2021

Oasis Fertility has announced the launch of its IVF center in the Karnataka region at HSR Layout, the city of Bengaluru. Dr. Durga G Rao inaugurated the center, Co-Founder and Medical Director Kiran Gadela, Co-Founder and Managing Director, Oasis Fertility, Oasis Fertility, with Dr. Krishna Chaitanya, Scientific Head and Clinical Embryologist, Oasis Fertility. Saalumarada Thimmakka was the Chief Guest of Honour, an Indian Environmentalist, and Padma Shri Awardee 2019.

Regional Analysis:    

Considering the global scenario of the market, America is the highest revenue generator in this market. The Americas mainly include North America and Latin America. Due to advanced healthcare facilities and high healthcare expenditure, US is the dominating country in this region. Europe is the second largest market for varicocele treatment. France is dominating this market while UK is the fastest growing varicocele treatment market. Asia Pacific is witnessing rapid growth in this market which is mainly due to improving healthcare facilities, increasing awareness of this disorder, and increasing healthcare expenditure. Middle East & Africa is expected to have limited growth.

Key players:      

• Bayer (Germany)


• Depomed, Inc. (US)


• GlaxoSmithKline plc. (UK)


• INSYS THERAPEUTICS, INC. (US)


• Janssen Global Services


• LLC (Belgium)


• Mylan N.V. (US)


• Novartis AG (Switzerland)


• PurduePharma (US)


• Pfizer Inc. (US)

The report for Global Varicocele Treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions

Report Scope:

Report Attribute/Metric	Details
Market Size	USD 0.6 Billion
CAGR	6.5%
Base Year	2021
Forecast Period	2023-2032
Historical Data	2020
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Grade, Diagnosis, Treatment, End user
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Bayer (Germany), Depomed, Inc. (US), GlaxoSmithKline plc. (UK), INSYS THERAPEUTICS, INC. (US), Janssen Global Services, LLC (Belgium) Mylan N.V. (US), Novartis AG (Switzerland), PurduePharma (US), Pfizer Inc
Key Market Opportunities	·  America is the highest revenue generator in this market·  Advanced healthcare facilities and high healthcare expenditure in US·  increasing healthcare expenditure in APAC
Key Market Drivers	·  Increasing prevalence of varicocele·  Increasing awareness of the disease·  Rising healthcare expenditure·  Advanced diagnosis and treatment options